Parabilis Medicines Financials - Benzinga

Parabilis Medicines Inc

PBLSNASDAQ

Trade with Public

Trade with Public

$37.22

0.150.4%

At close: Aug 17, 5:00 PM EST

$38.00

0.782.1%

After Hours: 5:36 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Parabilis Medicines Financials

Parabilis Medicines (PBLS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate

Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.08) by 2800 percent. This is a 89.59 percent increase over losses of $(22.28) per share

Benzinga Newsdesk